Trial Profile
Dose-dense nonpegylated liposomal Doxorubicin and docetaxel combination in breast cancer: dose-finding study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Feb 2016
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Doxorubicin liposomal (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 08 Feb 2016 New trial record